SciencePart 2 of 3 in Risks & monitoring

Testosterone Therapy Suppresses Sperm Production — Which Is Why It's the First Question

Replacing testosterone shuts down the signal that tells the testes to make sperm. That is not a rare side effect; it is the expected pharmacology. Recovery after stopping is common but not universal, and not quick.

By
Keen Clinician Team
Published
August 11, 2026
Last reviewed
August 11, 2026
Read time
4 min
Sources
2 cited

Testosterone replacement suppresses the hypothalamic-pituitary-gonadal axis, and suppressing that axis reduces sperm production.[1] This is the expected mechanism, not an unusual reaction. It is also why "are you planning children in the near term?" is the very first item on the Endocrine Society's list of reasons not to start testosterone therapy.[2]

If nobody has asked you that question, the conversation has skipped a step.

Why replacing testosterone stops sperm production

The testes make sperm in response to signalling from the pituitary. That signalling is regulated by how much testosterone the brain detects in circulation.

Supply testosterone from outside the body and the brain reads the level as sufficient, so it reduces the signal. Circulating testosterone goes up; the intratesticular environment sperm production depends on goes down. Both TRT and anabolic-androgenic steroid use suppress the HPG axis, with the same consequence for spermatogenesis.[1]

This is why a man on TRT can have excellent blood testosterone numbers and a very poor semen analysis at the same time. The two are measuring different compartments.

What recovery actually looks like

A review in the Asian Journal of Andrology covering recovery after TRT or AAS use describes the realistic picture: stopping may result in spontaneous recovery of normal spermatogenesis in a reasonable number of men, if given sufficient time — but some men do not recover normal spermatogenesis, and others cannot tolerate waiting for spontaneous recovery.[1]

Three things in that sentence are worth holding onto.

"Reasonable number," not "all." Recovery is common. It is not guaranteed.

"Sufficient time" is doing real work. This is measured in months, not weeks.

There are pharmacological options when it does not happen on its own. The review discusses injectable gonadotropins, selective estrogen receptor modulators and aromatase inhibitors — and is explicit that their off-label use in this setting is poorly described in the literature, which it identifies as a knowledge gap for clinicians.[1] That is an honest characterisation of the evidence, and worth knowing before treating recovery as a solved problem.

If you want children and you have low testosterone

Having low testosterone and wanting to preserve fertility are not mutually exclusive, and the guideline's position is not "no treatment ever." It recommends against starting testosterone therapy in men planning fertility in the near term.[2] That is a statement about this treatment, at this time — not about your options generally.

What follows from it is a conversation about sequencing and about approaches that do not suppress the axis. Those decisions belong with a clinician who knows your situation, ideally one comfortable with male fertility specifically.

If you are already on treatment

Raise it. The review's framing is that clinicians should recognise previous TRT or AAS use in men presenting with infertility, precisely because the connection is often not made.[1] Stopping is a decision with its own consequences and should not be made unilaterally, but the question of whether your current protocol fits your plans is a fair one to reopen at any point.

Frequently asked questions

Is TRT a contraceptive? No. Suppression of sperm production is real but not reliable or complete enough to be used as contraception, and it should never be treated as such.

How long until sperm production recovers after stopping? The review describes spontaneous recovery in a reasonable number of men given sufficient time, without a universal timeline — recovery varies, and some men do not recover normal spermatogenesis at all.[1] A semen analysis, not a calendar, is what answers this for an individual.

Will my testosterone level tell me anything about my fertility? Very little while you are on treatment. Serum testosterone and sperm production are measuring different things, which is the whole reason this side effect surprises people.

Does the delivery method change this? The suppression comes from raising circulating testosterone and the brain responding to it. That mechanism is not specific to any one formulation.

The question to ask first

Before starting any testosterone therapy: do I want children, and if so, when? It is the first item on the guideline's do-not-start list,[2] and the only one that costs nothing to check.

Keen connects you with a licensed clinical team for a telehealth consultation and lab review. If your testosterone is clinically low, treatment is Keen Testosterone Spray Rx — a once-daily topical spray powered by Hypospray® transdermal delivery.

Related reading: erythrocytosis and hematocrit and your first testosterone test.

References

2 sources
  1. McBride JA, Coward RM. Recovery of spermatogenesis following testosterone replacement therapy or anabolic-androgenic steroid use. Asian J Androl. 2016;18(3):373–380. doi:10.4103/1008-682X.173938 · PMID 26908067
  2. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229 · PMID 29562364

Hypospray® is a registered trademark. Keen Meds Inc. utilizes the Hypospray® topical transdermal delivery platform under license.

Feel like yourself again.